Jellagen develops collagen-based innovations for advanced wound and tissue healing, self-described as capable of addressing complex, regenerative medical needs.

Jellagen

Jellagen | 3,006 followers on LinkedIn. A Revolutionary Platform for Regenerative Medicine | Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research.

At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.

Stéphane Thiroloix

Executive, Board Member, Investor, Advisor, ex-CMO Smith+Nephew

Andy Weymann

CEO at Jellagen

Thomas-Paul Descamps

Quality Manager at Jellagen

Rhodri Allen

We have an rare opportunity for someone to join the team at an exciting time for Jellagen. If you want more information or have any questions, please reach out to hr@jellagen.co.uk otherwise please apply for the role and we look forward to speaking to you.

Jellagen is excited to be attending MEDICA 2023 in Dusseldorf and to be part of the Welsh Pavilion of exhibitors (Hall 16 Booth H38). #investwales ; #Trade &InvestWales; #collagen ; #biomaterials ; #tissueengineering ; #medicaldevice

Jellagen is excited to announce the publication in Materials Today Bio results from new research developed in collaboration with the National Physical Laboratory (NPL) demonstrating further jellyfish Collagen Type 0 as the foundation for a range of new medical applications and to support new biological research. For full details, please follow the links: https://lnkd.in/grbf6um2 https://lnkd.in/gxhScGM8 #collagen #biomaterials #tissueengineering #marinebiotechnology #cellculture #medicaldevice #medicaldevices #collaboration #biotechnology #stemcells #3dcellculture #organoids

CrUX Dataset

Facebook Sharer

CrUX Top 50m

Business Management

Office Manager

Rhys Norbury

Inside Sales Manager

Robbie Oliver

Digital Marketing Manager

Adam Watts

Head of Research and Process Development

David Williams

Finance Assistant

Debbie Gilbert

Quality / Operations Associate

Ffion McGurk

Ffion Smith

Business Development Executive

Georgia Mountfield

Research Scientist

Rochelle Ahmed

Galvin Mould

Chairman

Andrew Mearns Spragg

Co-founder & CEO

Europe Early Stage Companies With Less Than $500M in Revenue

Health Care Companies With Less Than $10M in Revenue (Top 10K)

United Kingdom Startups Founded in 2013

United Kingdom Early Stage Companies With Fewer Than 100 Employees

Jellagen is a Med-Tech company offering high-grade native collagen sourced from jellyfish. jellyfish collagen is applicable for tissue engineering, regenerative medicine, stem cell research, and a wide variety of cell culture applications. currently supply native collagen for cell culture research supplied in solution or powder.

Cardiff Capital Region

Series A - Jellagen

Newable Private Investing

Venture Round - Jellagen

Innovate UK

Grant - Jellagen

Development Bank of Wales

Pembroke Dock

Pembrokeshire

United Kingdom

Europe

500-million-year-old jellyfish collagen could be key to lab grown organs

Jellyfish Gel That Arose 500 Million Years Ago Will Help Make Model Organs

Jellagen Closes £8.7M Series A Funding

Jellagen® Ltd Announces Collaboration With Mayo Clinic

Collagen Solutions sells stake in jellyfish products group Jellagen

Jellagen Launches Next-Gen Jellyfish Collagen Facility

HTML5

jQuery

Google Maps API

Microsoft Outlook

Gravity Forms

Google Fonts

Wordpress

Google Tag Manager

Apache Server

Google Compute Engine

Jellagen develops collagen-based innovations to address regenerative medical needs, enabling the creation of medical treatments. The company's products utilize non-mammalian collagen sourced from jellyfish.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Nov 3, 2024 6:57 PM	1f5b3946
public peers	general	Nov 6, 2024 8:16 AM	f9b48783
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Nov 3, 2024 4:40 AM	c976052b
company summary	general
signals	general	Nov 6, 2024 8:16 AM	43e6dfa0
crunchbase trigger	general	Nov 6, 2024 8:16 AM	013cdfe9
crunchbase profile	general	Nov 6, 2024 1:35 PM	daeb3241
li profile	general	Nov 6, 2024 8:16 AM	41feec20
translate crunchbase fundingrounds	general	Nov 6, 2024 2:16 PM	c34f54c2
peers	general	Nov 6, 2024 8:16 AM	26dd2c76
news basic	general	Nov 6, 2024 8:16 AM	7efdee51
bundesanzeiger	filings
financials download nd	financials
private financials	financials

CO

UK:CO:JELLAGEN

Jellagen